Osteoporosis : News
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
|
A new US study found that even short term use of oral bisphosphonates like Fosomax , commonly used to treat osteoporosis, may leave the jaw vulnerable to devastating necrosis .
|
|
Researchers at the University Of Southern California, School Of Dentistry release results of clinical data that links oral bisphosphonates to increased jaw necrosis.
|
|
Saturday, January 03, 2009 The proportion of people taking widely prescribed oral osteoporosis drugs who develop a nasty jaw condition may be much higher than previously thought, a new study suggests.
|
|
Women who took the osteoporosis drug Fosamax for up to three years saw an increase in their number of osteoclasts, or cells that remove old, brittle bone, a new study says.
|
|
Women taking tablets to protect their bones from osteoporosis could be at risk of serious jaw damage, claim researchers.
|
|
A popular osteoporosis drug made by pharma company, Merck, has been found to carry a possible risk for esophageal cancer.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.